Positron (OTC: POSC) Bags Key Agreement for PET-CT 64-Slice Scanners
The molecular imaging medical device company Positron Corporation (OTC: POSC) may be one of the companies to keep an eye on this morning after the developments from yesterday. The company hit the news wires yesterday with regard to an agreement for three of its NeuSight Slice Scanners.
New Agreement
As ever, new agreements like these are often seen positively by investors, and yesterday, the company announced that it had entered into the agreement for the scanners under the provisions of the Prime Rental Program. The agreement was reached with an unnamed but leading cardiovascular management, diagnostics, and treatment practice. Positron further noted that it remained committed to assisting such major players in the world of cardiovascular health so as to advance nuclear cardiology.
Further Information
The company further noted that the scanners in question had been developed for the purpose of changing the face of cardiac PET imaging through the combination of great value, outstanding performance, and high-tech technology. More importantly, it was one of the few cost-effective products of its kind that performed exceptionally in the realms of both oncology and cardiology. It may be a good time to add Positron Corporation to the watch lists.
Management Quote
Adel Abdullah, President of Positron, stated, “We are proud to support innovators in nuclear cardiology and help our customers uphold the highest standards of cardiac care. Our comprehensive rental program ensures accessibility, while our expert team provides the training and support needed for continued success.” Mr. Abdullah added, “Positron delivers the best in cardiac PET and PET-CT imaging, empowering physicians with advanced technology, including data quantification and CFR applications. Our solutions combine cutting-edge performance and comprehensive support services with cost-effectiveness, which provides the ideal choice for nuclear imaging practices.”
Fundamentals
| P/E Ratio | -26.63 |
| PEG Ratio | – |
| Price to Book | -39.82 |
| Price to Cash Flow | – |
| Price to Free Cash Flow | – |
| Total Sales (TTM) | 0.62 M |
| Revenue per Share (TTM) | 0.02 |
| Shares Outstanding | 14.276 M |
| Share Float (%) | 11.00 M (77.05%) |
| % Held by Institutions | 0.00 |